mRNA expression of genes involved in inflammation and haemostasis in equine fibroblast-like synoviocytes following exposure to lipopolysaccharide, fibrinogen and thrombin

BMC Veterinary Research

Stine Jacobsen¹  Annemarie T. Kristensen²  Søren Saxmose Nielsen³  Lise C. Berg²  Stine Mandrup Andreassen¹ 

[1] Department of Large Animal Sciences, Medicine and Surgery group, University of Copenhagen, Højbakkegård allé 5, Tåstrup, DK-2630, Denmark;Department of Veterinary Clinical and Animal Sciences, University of Copenhagen, Dyrlægevej 16, Frederiksberg C, DK-1870, Denmark;Department of Large Animal Sciences, University of Copenhagen, Grønnegårdsvej 8, Frederiksberg C, DK-1870, Denmark

关键词: Haemostasis;    Fibrinolysis;    Coagulation;    Inflammation;    mRNA expression;    Thrombin;    Lipopolysaccharide;    Fibrinogen;    Fibroblast-like synoviocytes;    Equine;   

Others  :  1219100
DOI  :  10.1186/s12917-015-0448-z

 received in 2014-09-23, accepted in 2015-06-01,  发布年份 2015

【 摘 要 】

Background

Studies in humans have shown that haemostatic and inflammatory pathways both play important roles in the pathogenesis of joint disease. The aim of this study was to assess mRNA expression of haemostatic and inflammatory factors in cultured equine fibroblast-like synoviocytes exposed to lipopolysaccharide (LPS), fibrinogen and thrombin. Synovial membranes were collected from metacarpo-phalangeal joints of 6 skeletally mature horses euthanized for non-orthopaedic reasons. Passage 4 fibroblast-like synoviocytes were left non-treated or treated with either 0.1 μg/ml LPS, 5 mg/ml fibrinogen or 5 U/ml thrombin and harvested at time points 0, 6, 24 and 48 h. mRNA expression of serum amyloid A (SAA), interleukin-6 (IL-6), monocyte chemotactic protein 1 (MCP-1), tissue factor (TF), plasminogen activator inhibitor 1 (PAI-1), urokinase plasminogen activator (uPA), vascular endothelial growth factor (VEGF) and protease activator receptor 1 (PAR-1) was assessed using quantitative real time reverse transcriptase PCR.

Results

LPS caused a significant increase in mRNA expression of SAA, IL-6, MCP-1 and uPA, and a decrease in TF, PAI-1 and PAR-1 when compared to non-treated cells. Treatment with thrombin resulted in increased mRNA expression of SAA, IL-6, MCP-1 and PAI-1, and a decreased PAR-1 expression compared to non-treated cells. The fibrinogen-treated synoviocytes showed significantly increased mRNA expression of IL-6, MCP-1, TF and PAI-1, and decreased PAR-1 expression compared to non-treated cells.

Conclusion

LPS, fibrinogen and thrombin induced an increased gene expression of inflammatory markers in isolated equine fibroblast-like synoviocytes. LPS caused changes in gene expression promoting increased fibrinolysis, while fibrinogen and thrombin changed the gene expression resulting potentially in reduced fibrinolysis. Overall, it appeared that both inflammatory and haemostatic stimuli affected expression of genes involved in inflammatory and haemostatic pathways, supporting their importance in equine joint diseases.

【 授权许可】

   
2015 Andreassen et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

Fig. 6.

Fig. 7.

Fig. 8.

【 参考文献 】

• [1]Jonsson L, Roepstorff L, Egenvall A, Nasholm A, Dalin G, Philipsson J. Prevalence of clinical findings at examinations of young Swedish warmblood riding horses. Acta Vet Scand. 2013; 55:34. BioMed Central Full Text
• [2]Ireland JL, Clegg PD, McGowan CM, McKane SA, Chandler KJ, Pinchbeck GL. Disease prevalence in geriatric horses in the United Kingdom: Veterinary clinical assessment of 200 cases. Equine Vet J. 2012; 44:101-6.
• [3]Murray RC, Walters JM, Snart H, Dyson SJ, Parkin TDH. Identification of risk factors for lameness in dressage horses. Vet J. 2010; 184:27-36.
• [4]Bertone AL, Palmer JL, Jones J. Synovial fluid cytokines and eicosanoids as markers of joint disease in horses. Vet Surg. 2001; 30:528-38.
• [5]McIlwraith CW. Use of synovial fluid and serum biomarkers in equine bone and joint disease: a review. Equine Vet J. 2005; 37:473-82.
• [6]Kidd JA, Barr ARS, Tarlton JF. Use of matrix metalloproteinases 2 and 9 and white blood cell counts in monitoring the treatment and predicting the survival of horses with septic arthritis. Vet Rec. 2007; 161:329-34.
• [7]Lindegaard C, Gleerup KB, Thomsen MH, Martinussen T, Jacobsen S, Andersen PH. Anti-inflammatory effects of intra-articular administration of morphine in horses with experimentally induced synovitis. Am J Vet Res. 2010; 71:69-75.
• [8]Ross TN, Kisiday JD, Hess T, McIlwraith CW. Evaluation of the inflammatory response in experimentally induced synovitis in the horse: a comparison of recombinant equine interleukin 1 beta and lipopolysaccharide. Osteoarthritis Cartilage. 2012; 20:1583-90.
• [9]Kamm JL, Nixon AJ, Witte TH. Cytokine and catabolic enzyme expression in synovium, synovial fluid and articular cartilage of naturally osteoarthritic equine carpi. Equine Vet J. 2010; 42:693-9.
• [10]Chang SK, Gu Z, Brenner MB. Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11. Immunol Rev. 2010; 233:256-66.
• [11]Briston L, Dudhia J, Lees P. Age-related differences in prostaglandin E(2) synthesis by equine cartilage explants and synoviocytes. J Vet Pharmacol Ther. 2010; 33:268-76.
• [12]Del Rey MJ, Usategui A, Izquierdo E, Canete JD, Blanco FJ, Criado G et al.. Transcriptome analysis reveals specific changes in osteoarthritis synovial fibroblasts. Ann Rheum Dis. 2012; 71:275-80.
• [13]Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis. 2005; 64:1263-7.
• [14]Chiu YC, Fong YC, Lai CH, Hung CH, Hsu HC, Lee TS et al.. Thrombin-induced IL-6 production in human synovial fibroblasts is mediated by PAR1, phospholipase C, protein kinase C alpha, c-Src, NF-kappa B and p300 pathway. Mol Immunol. 2008; 45:1587-99.
• [15]So AK, Varisco PA, Kemkes-Matthes B, Herkenne-Morard C, Chobaz-Peclat V, Gerster JC et al.. Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost. 2003; 1:2510-5.
• [16]Armstrong S, Lees P. Effects of carprofen (R and S enantiomers and racemate) on the production of IL-1, IL-6 and TNF-alpha by equine chondrocytes and synoviocytes. J Vet Pharmacol Ther. 2002; 25:145-53.
• [17]Busso N, Morard C, Salvi R, Peclat V, So A. Role of the tissue factor pathway in synovial inflammation. Arthritis Rheum. 2003; 48:651-9.
• [18]Flick MJ, LaJeunesse CM, Talmage KE, Witte DP, Palumbo JS, Pinkerton MD et al.. Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif. J Clin Invest. 2007; 117:3224-35.
• [19]Salvi R, Peclat V, So A, Busso N. Enhanced expression of genes involved in coagulation and fibrinolysis in murine arthritis. Arthritis Res. 2000; 2:504-12. BioMed Central Full Text
• [20]Jacobsen S, Niewold TA, Halling-Thomsen M, Nanni S, Olsen E, Lindegaard C et al.. Serum amyloid A isoforms in serum and synovial fluid in horses with lipopolysaccharide-induced arthritis. Vet Immunol Immunopathol. 2006; 110:325-30.
• [21]Kitamoto Y, Nakamura E, Kudo S, Tokunaga H, Murakami E, Noguchi K et al.. Thrombin in synovial fluid as a marker of synovial inflammation: a definite measurement by ELISA and correlation with VEGF. Clin Chim Acta. 2008; 398:159-60.
• [22]Russell FA, McDougall JJ. Proteinase activated receptor (PAR) involvement in mediating arthritis pain and inflammation. Inflamm Res. 2009; 58:119-26.
• [23]Alturfan AA, Eralp L, Emekli N. Investigation of inflammatory and hemostatic parameters in female patients undergoing total knee arthroplasty surgery. Inflammation. 2008; 31:414-21.
• [24]Liu XF, Piela-Smith TH. Fibrin(ogen)-induced expression of ICAM-1 and chemokines in human synovial fibroblasts. J Immunol. 2000; 165:5255-61.
• [25]Masamune A, Kikuta K, Watanabe T, Satoh K, Hirota M, Hamada S et al.. Fibrinogen induces cytokine and collagen production in pancreatic stellate cells. Gut. 2009; 58:550-9.
• [26]Sanchez-Pernaute O, Lopez-Armada MJ, Calvo E, Diez-Ortega I, Largo R, Egido J et al.. Fibrin generated in the synovial fluid activates intimal cells from their apical surface: a sequential morphological study in antigen-induced arthritis. Rheumatology (Oxford). 2003; 42:19-25.
• [27]Ribera T, Rios J, Prades M, Monreal L, Delgado MA: Synovial fibrinolysis activity in horses with inflammatory joint/tendon sheath disease. Annual Congress of the European College of Veterinary Surgery (ECVS), Helsinki, Finland. July 2010
• [28]Ribera T, Monreal L, Delgado MA, Rios J, Prades M. Synovial fluid d-dimer concentration in horses with osteochondritis dissecans and osteoarthritis. Vet Comp Orthop Traumatol. 2013; 26:54-60.
• [29]Haerdi-Landerer MC, Steiner A, Suter MM. Primary bovine synoviocyte cultures: A useful tool for in vitro drug testing? Vet J. 2011; 188:58-63.
• [30]Upragarin N, van Asten AJAM, Tooten PCJ, Landman WJM, Gruys E. Serum amyloid A production by chicken fibroblast-like synoviocytes. Vet Immunol Immunopathol. 2005; 106:39-51.
• [31]Santangelo KS, Johnson AL, Ruppert AS, Bertone AL. Effects of hyaluronan treatment on lipopolysaccharide-challenged fibroblast-like synovial cells. Arthritis Res Ther. 2007; 9:R1. BioMed Central Full Text
• [32]Busso N, Peclat V, So A, Sappino AP. Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis. 1997; 56:550-7.
• [33]Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res. 2004; 114:321-7.
• [34]Frisbie DD, Al-Sobayil F, Billinghurst RC, Kawcak CE, McIlwraith CW. Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses. Osteoarthritis Cartilage. 2008; 16:1196-204.
• [35]van den Boom R, van der Harst MR, Brommer H, Brama PA, Barneveld A, van Weeren PR et al.. Relationship between synovial fluid levels of glycosaminoglycans, hydroxyproline and general MMP activity and the presence and severity of articular cartilage change on the proximal articular surface of P1. Equine Vet J. 2005; 37:19-25.
• [36]Ribera T, Monreal L, Armengou L, Rios J, Prades M. Synovial fluid d-dimer concentration in foals with septic joint disease. J Vet Intern Med. 2011; 25:1113-7.
• [37]Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol. 2012; 34:43-62.
• [38]Hoppe B, Dorner T. Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis. Nat Rev Rheumatol. 2012; 8:738-46.
• [39]Ogura N, Satoh K, Akutsu M, Tobe M, Kuyama K, Kuboyama N et al.. MCP-1 production in temporomandibular joint inflammation. J Dent Res. 2010; 89:1117-22.
• [40]Ovlisen K, Kristensen AT, Jensen AL, Tranholm M. IL-1 beta, IL-6, KC and MCP-1 are elevated in synovial fluid from haemophilic mice with experimentally induced haemarthrosis. Haemophilia. 2009; 15:802-10.
• [41]Villiger PM, Terkeltaub R, Lotz M. Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol. 1992; 149:722-7.
• [42]Harigai M, Hara M, Yoshimura T, Leonard EJ, Inoue K, Kashiwazaki S. Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunop. 1993; 69:83-91.
• [43]Colotta F, Sciacca FL, Sironi M, Luini W, Rabiet MJ, Mantovani A. Expression of monocyte chemotactic protein-1 by monocytes and endothelial-cells exposed to thrombin. Am J Pathol. 1994; 144:975-85.
• [44]Harley SL, Powell JT. Fibrinogen up-regulates the expression of monocyte chemoattractant protein 1 in human saphenous vein endothelial cells. Biochem J. 1999; 341:739-44.
• [45]Seeger FH, Blessing E, Gu L, Bornhold R, Denger S, Kreuzer J. Fibrinogen induces chemotactic activity in endothelial cells. Acta Physiol Scand. 2002; 176:109-15.
• [46]Barton MH, Collatos C, Moore JN. Endotoxin induced expression of tumour necrosis factor, tissue factor and plasminogen activator inhibitor activity by peritoneal macrophages. Equine Vet J. 1996; 28:382-9.
• [47]Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb Haemost. 2001; 85:958-65.
• [48]Busso N, Hamilton JA. Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis. Arthritis Rheum. 2002; 46:2268-79.
• [49]Bokarewa MI, Morrissey JH, Tarkowski A. Tissue factor as a proinflammatory agent. Arthritis Res. 2002; 4:190-5. BioMed Central Full Text
• [50]Nonaka T, Kikuchi H, Ikeda T, Okamoto Y, Hamanishi C, Tanaka S. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis. J Rheumatol. 2000; 27:997-1004.
• [51]Alpay Z, Saed GM, Diamond MP. Postoperative adhesions: from formation to prevention. Semin Reprod Med. 2008; 26:313-21.
• [52]Levi M, van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med. 2005; 15:254-9.
• [53]Yang YH, Hall P, Little CB, Fosang AJ, Milenkovski G, Santos L et al.. Reduction of arthritis severity in protease-activated receptor-deficient mice. Arthritis Rheum. 2005; 52:1325-32.
• [54]Furuhashi I, Abe K, Sato T, Inoue H. Thrombin-stimulated proliferation of cultured human synovial fibroblasts through proteolytic activation of proteinase-activated receptor-1. J Pharmacol Sci. 2008; 108:104-11.
• [55]Hirano F, Kobayashi A, Hirano Y, Nomura Y, Fukawa E, Makino I. Thrombin-induced expression of RANTES mRNA through protease activated receptor-1 in human synovial fibroblasts. Ann Rheum Dis. 2002; 61:834-7.
• [56]Lang R, Song PI, Legat FJ, Lavker RM, Harten B, Kalden H et al.. Human corneal epithelial cells express functional PAR-1 and PAR-2. Invest Ophthalmol Vis Sci. 2003; 44:99-105.
• [57]Mbebi C, Rohn T, Doyennette MA, Chevessier F, Jandrot-Perrus M, Hantai D et al.. Thrombin receptor induction by injury-related factors in human skeletal muscle cells. Exp Cell Res. 2001; 263:77-87.
• [58]Zhao AP, Dawson H, Urban JF, Finkelman FD, Shea-Donohue T. Up-regulation of PAR-1 and PAR-2 expression contributes to nematode-induced hypercontractility of murine intestinal smooth muscle. Gastroenterol. 2003; 124:A89-9.
• [59]Ellis CA, Tiruppathi C, Sandoval R, Niles WD, Malik AB. Time course of recovery of endothelial cell surface thrombin receptor (PAR-1) expression. Am J Physiol. 1999; 276:C38-45.
• [60]Pompili E, Fabrizi C, Fumagalli L. PAR-1 upregulation by trimethyltin and lipopolysaccharide in cultured rat astrocytes. Int J Mol Med. 2006; 18:33-9.
• [61]Rohatgi T, Henrich-Noack P, Sedehizade F, Goertler M, Wallesch CW, Reymann KG et al.. Transient focal ischemia in rat brain differentially regulates mRNA expression of protease-activated receptors 1 to 4. J Neurosci Res. 2004; 75:273-9.
• [62]Yan W, Tiruppathi C, Qiao R, Lum H, Malik AB. Tumor necrosis factor decreases thrombin receptor expression in endothelial cells. J Cell Physiol. 1996; 166:561-7.
• [63]Yoo SA, Kwok SK, Kim WU. Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention. Med Inflam. 2008; 2008:129873.
• [64]Lee SS, Joo YS, Kim WU, Min DJ, Min JK, Park SH et al.. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2001; 19:321-4.
• [65]Ludin A, Sela JJ, Schroeder A, Samuni Y, Nitzan DW, Amir G. Injection of vascular endothelial growth factor into knee joints induces osteoarthritis in mice. Osteoarthritis Cartilage. 2013; 21:491-7.
• [66]Jansen H, Meffert RH, Birkenfeld F, Petersen W, Pufe T. Detection of vascular endothelial growth factor (VEGF) in moderate osteoarthritis in a rabbit model. Ann Anat. 2012; 194:452-6.
• [67]Kim CO, Huh AJ, Kim MS, Chin BS, Han SH, Choi SH et al.. LPS-induced vascular endothelial growth factor expression in rat lung pericytes. Shock. 2008; 30:92-7.
• [68]Shiose S, Hata Y, Noda Y, Sassa Y, Takeda A, Yoshikawa H et al.. Fibrinogen stimulates in vitro angiogenesis by choroidal endothelial cells via autocrine VEGF. Graef Arch Clin Exp. 2004; 242:777-83.
• [69]Huang YQ, Li JJ, Hu L, Lee M, Karpatkin S. Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes. Tromb Haemost. 2001; 86:1094-8.
• [70]Guo F, Liu J, Wang C, Liu N, Lu P. Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: pro-inflammatory effect on atherosclerosis. Biochem Bioph Res Co. 2009; 390:942-6.
• [71]Lu PP, Liu JT, Liu N, Guo F, Ji YY, Pang XM. Pro-inflammatory effect of fibrinogen and FDP on vascular smooth muscle cells by IL-6, TNF-alpha and iNOS. Life Sci. 2011; 88:839-45.
• [72]Haneda S, Nagaoka K, Nambo Y, Kikuchi M, Nakano Y, Matsui M et al.. Interleukin-1 receptor antagonist expression in the equine endometrium during the peri-implantation period. Domest Anim Endocrin. 2009; 36:209-18.
• [73]Deschene K, Celeste C, Boerboom D, Theoret CL. Constitutive expression of hypoxia-inducible factor-1 alpha in keratinocytes during the repair of skin wounds in horses. Wound Repair Regen. 2011; 19:250-9.
• [74]Iqbal J, Bird JL, Hollander AP, Bayliss MT. Effect of matrix depleting agents on the expression of chondrocyte metabolism by equine chondrocytes. Res Vet Sci. 2004; 77:249-56.
• [75]Tellmann GG. O: LightCycler® 480 Real-Time PCR system: Innovative solutions for relative quantification. Biochemica. 2006; 4:16-7.
• [76]R: A language and environment for statistical computing. http://www. R-project.org webcite